Toragen is focused on uniquely selective drugs targeting cancers caused by the human papillomavirus (“HPV”)SAN DIEGO (BUSINESS WIRE) Toragen, Inc., a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs targeting cancers caused by the human papilloma.